Recursion
This role leads a team building and optimizing the machine learning infrastructure powering Recursion's drug discovery platform. Responsibilities include managing model training pipelines, production deployment systems, and agent infrastructure for Large Language Models across supercomputing environments. The position requires cross-functional collaboration with engineering, data science, and research teams to ensure scalable ML solutions.
Headquarters
Salt Lake City, Utah, United States
Company Size
501-1000 employees
Founded
2013
Recursion is a TechBio company that combines high-throughput experimental biology, automated imaging, and machine learning to decode biology and accelerate drug discovery. Its platform integrates large-scale biological datasets, AI models, and laboratory automation to identify and advance therapeutic candidates across multiple modalities and disease areas. Recursion develops an internal pipeline of programs and partners with biopharma and investors to translate discoveries into clinical-stage medicines. The company emphasizes a platform-first, scalable approach to make drug discovery faster, more reproducible, and more data-driven.
A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress
9 hours ago
Recursion Pharmaceuticals (NASDAQ:RXRX) CEO Sells $94,798.30 in Stock
17 hours ago
Recursion’s First AI Clinical Proof Links Pipeline Progress With Valuation Gap
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Recursion.
Recursion didn’t post a salary, so this is our estimate from similar listings.
PacBio appoints Recursion co-founder Gibson to board
2 days ago